Beilu Pharmaceutical: Net profit in 2025 was 92.73 million yuan, turning a loss compared to the previous year.

Beilu Pharmaceutical announced that its operating income in 2025 was 1.205 billion yuan, an increase of 22.54% year-on-year. Net profit was 92.7347 million yuan, compared to a loss of 13.6517 million yuan in the same period last year. The company plans not to distribute cash dividends, bonus shares, or increase capital by converting reserves into share capital.